Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives.

[1]  S. Kuentzel,et al.  Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine. , 1971, Biochemical pharmacology.

[2]  W. Benedict,et al.  Kinetics of 1-beta-D-arabinofuranosylcytosine-induced chromosome breaks. , 1970, Cancer research.

[3]  G. Gray,et al.  The immunosuppressive activity of adamantoyl cytarabine. 3. Immunosuppressive specificity in rats. , 1970, Immunology.

[4]  J. Edmonson,et al.  A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878). , 1970, Cancer research.

[5]  B. Juel-Jensen.  Severe generalized primary herpes treated with cytarabine. , 1970, British medical journal.

[6]  G. Neil,et al.  Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice. , 1970, Cancer research.

[7]  A. Schrecker.  Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts. , 1970, Cancer research.

[8]  M. Wade,et al.  Chemical suppression of primary and anamnestic maternal immunization of Rh-incompatible pregnancies. An animal model. , 1970, American journal of obstetrics and gynecology.

[9]  G. Bodey,et al.  Prolonged infusion of arabinosyl cytosine in childhood leukemia , 1970, Cancer.

[10]  H. Kwaan,et al.  Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia. , 1969, Blood.

[11]  S. Sternberg,et al.  Cytotoxic Effects of 1-β-d-Arabinofuranosyl-5-fluorocytosine and of 1-β-d-Arabinofuranosylcytosine in Proliferating Tissues in Mice , 1969 .

[12]  J. A. Crim,et al.  Immunosuppressive effects of adamantoyl cytarabine. I. Inhibition of hemagglutinin formation and graft versus host reactions in mice. , 1969, Biochemical pharmacology.

[13]  M. Wade,et al.  The production of tolerance to human erythrocytes in the rat with cytosine arabinoside or cyclophosphamide. , 1969, Journal of immunology.

[14]  J. Bickers,et al.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). , 1969, Cancer research.

[15]  W. Kreis,et al.  Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms. , 1969, Biochemical pharmacology.

[16]  J. A. Crim,et al.  THE IMMUNOSUPPRESSIVE ACTIVITY OF ARA-CYTIDINE (CYTARABINE): III. Effects On Canine Renal Allograft Rejection And Hemagglutinin Formation , 1969, Transplantation.

[17]  S. Shirakawa,et al.  The locus of action of 1-beta-d-arabinofuranosylcytosine in the cell cycle. , 1969, Cancer research.

[18]  M. Wade,et al.  Immunosuppressive effects of cytosine arabinoside and methotrexate in man. , 1969, Annals of internal medicine.

[19]  D. Rosenthal,et al.  Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro. , 1969, Cancer research.

[20]  L. Burić,et al.  Deoxycytidine and Radiation Response: Exceedingly High Deoxycytidine Aminohydrolase Activity in Human Liver , 1969, Science.

[21]  J. Harris,et al.  The effect of 1-beta-D-arabinofuranosylcytosine on the immune response of mice to sheep red blood cells. , 1968, Cancer research.

[22]  J. Furth,et al.  Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine , 1968 .

[23]  J. A. Crim,et al.  THE IMMUNOSUPPRESSIVE ACTIVITY OF ARA-CYTIDINE: I. Effects on Antobody-Forming Cells and Humoral Antibody , 1968, Transplantation.

[24]  J. A. Crim,et al.  THE IMMUNOSUPPRESSIVE ACTIVITY OF ARA-CYTIDINE: II. Effects on the Graft-versus-Host Reaction , 1968, Transplantation.

[25]  D. Kessel.  Properties of deoxycytidine kinase partially purified from L1210 cells. , 1968, The Journal of biological chemistry.

[26]  D. Kessel,et al.  Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia. , 1968, Biochimica et biophysica acta.

[27]  G. A. Fischer,et al.  The action of arabinosylcytosine on synchronously growing populations of mammalian cells. , 1968, Biochemical and biophysical research communications.

[28]  W. Wechter.  Nucleic acids. I. The synthesis of nucleotides and dinucleoside phosphates containing ara-cytidine. , 1967, Journal of medicinal chemistry.

[29]  C. G. Smith,et al.  Nucleic acids. II. Cytotoxicity studies with nucleotides and dinucleoside phosphates containing ara-cytidine. , 1967, Journal of medicinal chemistry.

[30]  I. Wodinsky,et al.  Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine Arabinoside , 1967, Science.

[31]  D. Kau,et al.  The adamantyl group in medicinal agents. 3. Nucleoside 5'-adamantoates. The adamantoyl function as a protecting group. , 1967, Journal of medicinal chemistry.

[32]  P. Calabresi,et al.  Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. , 1966, Biochemical pharmacology.

[33]  A. D. Welch,et al.  Immunosuppression by pyrimidine nucleoside analogs. , 1966, Biochemical pharmacology.

[34]  A. Goldin,et al.  Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules. , 1966, Cancer research.

[35]  C. G. Smith,et al.  Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. , 1967, Biochemical pharmacology.

[36]  R. T. Rapala,et al.  The adamantyl group in medicinal agents. II. Anabolic steroid 17-beta-adamantoates. , 1965, Journal of medicinal chemistry.

[37]  J. Evans,et al.  The Effect of 1-β-d-Arabinofuranosylcytosine Hydrochloride on Murine Neoplasms , 1964 .

[38]  F. J. Marshall,et al.  THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS. , 1963, Journal of medicinal chemistry.

[39]  M. Chu,et al.  A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells. , 1962, Biochemical pharmacology.